Hepatitis C virus and non-Hodgkin's lymphomas

Leukemia and Lymphoma

Volumn 22, Issue 1-2, 1996, Pages 53-60

  Pozzato, Gabriele ^a,d   Mazzaro, Cesare ^b   Santini, Gianfranco ^b   Burrone, Oscar ^c  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Pordenone General Hospital   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Epstein Barr virus; Hepatitis C virus; Mixed cryoglobulinemia; Non Hodgkin's lymphoma

Indexed keywords

AUTOIMMUNITY; BURKITT LYMPHOMA; CANCER RISK; CRYOGLOBULINEMIA; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HAIRY CELL LEUKEMIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; IMMUNE DEFICIENCY; NONHODGKIN LYMPHOMA; PERTHES DISEASE; PRIORITY JOURNAL; REVIEW; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS CARCINOGENESIS;

EID: 0029950064     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051728     Document Type: Review

References (88)

1. Harris, N.L., Jaffe, E.S., Stein, H. et al. (1994) A revised EuropeanAmerican classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84(45), 1361-1392.
2. The non-Hodgkin's lymphomapathologic classification group: NCI sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage (1982). Cancer, 49, 2112-2123.
3. Woods, J. S., Polissar, L., Severson, R. K. et al. (1987) Soft tissue sarcoma and non-Hodgkin's lymphomas in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington. J. Natl. Cancer Inst., 78, 899-905.
4. Hoar, S. K., Blair, A., Holmes, F. F. et al (1986) Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma. JAMA, 256, 1141-1148.
5. Colton, T. (1986) Herbicide exposure and cancer. JAMA, 256, 1176-1179.
6. Beebe, G. W., Kato, H. and Land, C. (1978) Studies on the mortality of A-bomb survivors: Mortality and radiation dose. Radial. Res., 75, 138-147.
7. Louie, S., Daoust, P. R. and Shwratz, R. S. (1980) Immunodeficiency and the pathogenesis of non-Hodgkin's lymphoma. Semin. Oncol., 7, 267-273.
8. Palackdharry, C. S. (1994) The epidemiology of non-Hodgkin's lymphomas: why the increased incidence? Oncology, 8 (8), 67-73.
9. Linet, M. S., Malker, H. S., McLaughlin, J. K. et al. (1993) Non-Hodgkin's lymphoma and occupation in Sweden: a registry based analysis. Br. J. Ind. Med., 50(1), 79-84.
10. Hatzissabas, I., Krueger, G. R., Medina, J. R., Bedoya, V. A. and Papadakis, T. (1993) Environmental pollution and malignant lymphomas: a tentative contribution to geographic pathology. Anticancer. Res., 13(2), 411-417.
11. Spector, B.D., Perry, G. S. and Kersey, J. H. (1978) Genetically determined immunodeficiency disease (GDID) and malignancy: A report from the Immunodeficiency Cancer Registry. Clin, Immunol. Immunopathol., 11, 12-19.
12. Talal, N. (1974) Autoimmunity and lymphoid malignancy in New Zealand black mice. Prog. Clin, Immunol., 2, 101-109.
13. Hanto, D. W., Frizzera, G., Gajl-Peczalska, K. J. et al. (1982) Epstein-Barr virus-induced B-cell lymphoma after renal transplantation. N. Engl. J. Med., 306, 913-918.
14. Cleary, M. L., Warnke, R. and Sklar, J. (1984) Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients. N. Engl. J. Med., 310, 477-81.
15. Kinlen, L. J., Shiel, A. G. R., Peto, J. and Doll, R. (1979) Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J., 7, 1461-1468.
16. Isomaki, H. A., Hakulinen, T. and Joutsenlathi, U. (1978) Excess risk of lymphomas, leukemia, and myeloma in patients with rheumatoid arthritis. J. Chronic Dis., 31, 691-702.
17. Wyburn-Mason, R. (1978) SLE and lymphoma. Lancet, 1, 156-8.
18. Kassan, S. S. (1978) Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med., 89, 888-892.
19. De Vita, S., Ferraccioli, G., De Re, V. et al. (1994) The polymerase chain reaction detects B cell clonalities in patients with Sjogren's syndrome and suspected malignant lymphoma. J. Rheumatol., 21(8), 1497-1501.
20. Holmes, G.T.K., Stokes, P.L., Sorahan, T.M. et al. (1976) Coeliac disease, gluten-free diet, and malignancy. Gut., 17, 612-618.
21. Brinker, H. and Wilbek, E. (1974) The incidence of malignant tumors in patients with respiratory sarcoidosis. Br. J. Cancer, 29, 247-253.
22. Martin, S. E. and Martin, W. J. (1975) Interspecies brain antigen detected by naturally occuring mouse anti-brain auto-antibody. Proc. Natl. Acad. Sci. USA. 72, 1036-1041.
23. Martin, W. J. and Martin, S. E. (1975) Thymus reactive IgM autoantibodies in normal mouse sera. Nature, 1975; 254, 716-718.
24. Walford, R. L. (1969) The immunological theory of aging. Copenhagen: Munksgaard.
25. Dighiero, G., Lymber, P., Guilbert, B. et al. (1986) Natural autoantibodies constitute a substantial part of normal circulating immunoglobulins. Ann. N.Y. Acad. Sci., 475, 135-145.
26. Baccala, R., Quang, T. V., Gilbert, M. et al. (1989) Two murine natural polyreactive antibodies are encoded by nonmutated germ-line genes. Proc. Natl. Acad. Sci. USA, 86, 4624-4628.
27. Kofler, R., Noonan, D. J., Levy, D. E. and Wilson, M. C. (1985) Genetic elements utilized for a murine lupus anti-DNA autoantibody are closely related to those for antibodies to exogenous antigens. J. Exp. Med., 161, 805-815.
28. Sela, B. A. et al. (1975) Antibodies reactive with cell surface carbohydrates Proc. Natl. Acad. Sci. USA, 254, 716-718.
29. Dziarski, R. (1988) Autoimmunity: polyclonal activation or antigen induction? Immunol. Today, 9, 340-342.
30. Klinman, D. and Steinberg, A. D. (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med., 165, 1755-1760.
31. Kritzman, J., Kunkel, H. G. and Mc Carthy, J. (1961) Studies of a Waldenstrom-type macroglobulin with rheumatoid factor properties. J. Lab. Clin. Med., 57, 905-912.
32. Chen, P. P., Kipps, I. J., Liu, F. T. and Carson, D. A. (1987) Isolation and characterization of a light chain variable region gene for human rheumatoid factors. J. Exp. Med., 166, 1900-1912.
33. Mayer, R. (1991) CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood, 75, 1518-1524.
34. Clearly, M. L., Mecker, T. C. and Levy, S. (1986) Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell, 44, 97-105.
35. Dighiero, G., Travade, P. and Binet, J. L. (1991) B-cell chronic lymphocytic leukemia: present status and future directions. Blood, 78, 1901-1914.
36. Shiramitzu, B., Barriga, F., Neequaye, J. et al. (1991) Pattern of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood, 77(7), 1516-1526.
37. Brousset, P., Knecht, H., Rubin, B. et al. (1993). Demonstration of Epstein-Barr virus replication in Reed-Stemberg cells of Hodgkin's disease. Blood, 82; 872-876.
38. Gallo, R. C. (1991) Human retrovirus: a decade of discovery and link with human disease, J. Inf. Dis. 164, 277-289.
39. Watherspoon, A. C., Hortiz-Hidalgo, C., Falzon, M. R. and Isaacson, P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338, 1175-1176.
40. Kaplan, L. D. (1988) AIDS-associated lymphomas. In The Medical Menagement of AIDS, Eds.: Sande, M. A. and Volberdinger, P. A. pp: 307-315. Publ.: Saunders, Philadelphia.
41. Epstein, M. A., Achang, B. G. and Barr, Y. H. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, 1, 702-706.
42. Zur Hausen, H. (1970) EBV DNA in biopsies of Burkitt tumor and anaplastic carcinoma of the nasopharynx. Nature, 228, 1056-1058.
43. Wolf, H., Hausen, H. Z., Becker, V. et al. (1973) EB-viral genomes in epithelial nasopharyngeal carcinoma cells. Nature, 244, 245-247.
44. Crawford, D. H., Thompson, J. H., Fernando, O. N. et al. (1980) Epstein-Barr virus nuclear antigen positive lymphoma after Cyclosporin A treatment in patients with renal allograft. Lancet, i, 1355-1356.
45. Murphy, J. K., Young, L. S., Bevan, I. S. et al. (1990) Demonstration of Epstein-Barr virus in primary lymphoma by in situ DNA hybridization in paraffin wax embedded tissue. J. Clin. Pathol., 43, 220-223.
46. Jones, J. F., Gottman, D., Katz, B. Z. and Tubbs, R. R. (1988) T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infection. N. Engl. J. Med., 318, 733-741.
47. Kikuta, H., Taguchi, Y. and Tomizawa, K. (1988) Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature, 333, 455-457.
48. Harabuchi, Y., Imai, S. and Kataura, A. (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128-130.
49. Anagnostopoulos, I., Herbst, H., and Stein, H. (1989) Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood, 74, 810-816.
50. Weiss, L. M., Movahed, L. A. and Warnke, R. A. (1989) Detection of Epstein-Barr virus genomes in Reed-stemberg cells of Hodgkin' s disease. N. Engl. J. Med., 320, 502-506.
51. Pallensen, G. (1991 ) Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet, 337, 320-322.
52. Cheeseman, S. H. (1988) Infectious mononucleosis, Sem. Hematol., 25, 261-268.
53. Henle, G., Henle, W., Diehl, V. et al. (1968) Relation of a Burkitt tumor associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA, 59, 94-101.
54. Nemerow, G. R., Moore, M. D. and Cooper, N. R. (1990) Structure and function of the B-lymphocyte Epstein-Barr virus/CD3d receptor. Adv. Cancer Res., 54, 273-300.
55. Henderson, S., Rowe, M., Gregory, C. and Croom-Carter, D. (1991) Induction of bcl-2 expression by Epstein-Barr virus Latent Membrane Protein-1 protects infected B cell from programmed cell death. Cell, 65, 1107-1115.
56. Thorley-Lawson, D. A. and Mann, K. P. (1985) Early events in Epstein-Barr virus infection provide a model for B-cell activation. J. Exp. Med., 162, 45-49.
57. Rowe, M., Hildreth, J. E., Rickinson, A. B. and Epstein, M. A. (1982) Monoclonal antibodies to Epstein-Barr virus-induced transformation-associated cell surface antigens: Binding patters and effectupon virus-specific cytotoxicity. Int. J. Cancer, 29, 373-381.
58. Magrath, I. (1990) The pathogenesis of Burkitt's lymphoma. Adv. Cancer. Res., 55, 133-270.
59. Rowe, M. Epstein-Barr virus and lymphoid malignancy. (1992) In Hoffbrand AV & Brenner M eds.; Recent advances in hematology. London: Churcill Livingstone, 6, 205-222.
60. Herbst, H., Hummel, M. and Pileri, S. (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Stemberg cells. Proc. Natl. Acad. Sci. USA, 88, 4766-4770.
61. Ballerini, P., Gaidano, G., Gong, J. Z. et al. (1993) Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood, 81(1), 166-176.
62. Watherspoon, A. C., Doglioni, C., Diss, T. C. et al. (1993) Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pilori. Lancet, 342, 575-577.
63. Grey, H. M. and Kohler, P. F. (1977) Cryoglobulins. Semin. Hematol, 10, 87-95.
64. Johnson, R. J., Gretch, D. R., Yamabe, H. et al. (1993) Membranoproliferative glomerulo-nephritis associated with hepatitis C virus. N. Engl. J. Med., 328, 465-471.
65. Ferri, C., Greco, F., Longobardo, G. et al. (1991) Association between hepatitis C virus and mixed cryoglobulinemia. Clin. Exp. Rheumatol., 9, 95-96.
66. Agnello, V., Chung, R. T. and Kaplan, L. M. (1992) A role for hepatitis C virus infection in type II cryoglobulinemia? N. Engl. J. Med., 327, 1490-1496.
67. Zignego, A. L., Macchia, D., Monti, M. et al. (1992) Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol., 15, 382-389.
68. Ferri, C., Monti, M., La Civita, L. et al. (1993) Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood, 82, 3701-3704.
69. Mazzaro, C., Santini, G. F., Pozzato, G. et al. (1995) Clinical and virological findings in mixed cryoglobulinemia. J. Int. Med., in press.
70. Santini, G. F., Crovatto, M., Modolo, M. L. et al. (1993) Waldenstrom's macroglobulinemia: a role of HCV infection ? Blood, 9, 2932 (Letter).
71. Broder, S., Humphrey R. and Drum, M. (1975) Impaired synthesis of polyclonal (non-paraprotein) immunoglobulins by lymphocytes from patients with multiple myeloma. N. Engl. J. Med., 293, 887-891.
72. Van Thiel, D. H., Fagiuoli, P., Caraceni, H. I. et al. (1995) Cryoglobulinemia: a cause of false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease. J. Hepatol 22(4), 464-467.
73. Mussini, M., Mascia, M. T., Zanni, G. and Curci, G. (1991) Bone marrow for the diagnosis of essential mixed type II cryoglobulinemia. Haematologica, 76, 389-391.
74. Pozzato, G., Mazzaro, C., Crovatto, M. et al. (1994) Mixed cryoglobulinemia, Non-Hodgkin's lymphomas and HCV infection. Blood. 84(9), 3047-3053.
75. Gorevic, P. D. and Frungione, B. (1991) Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative disease. Sem. Hematol., 28, 79-94.
76. Efremov, D. G., Batista, F. D. and Burrone, O. R. (1993) Molecular analysis of IgE heavy chain transcript expressed in vivo by peripheral blood lymphocytes from normal and atopic individuals. J. Immunol., 151, 2195-2207.
77. Franzin, F., Pozzato, G., Efremov, D. et al. (1995) Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br. J. Haematol in press.
78. Pagliaro, L., Saracci, R., Bardelli, D. and Filippazzo, G. (1982) Chronic liver disease, alcohol consumption and HBsAg in Italy: a multiregional case-control study. It. J. Gastroenterol. 14, 90-95.
79. D'Amico, G., Morabito, A., Pagliaro, L., Marubini, E. and the liver study group of "Cervello" Hospital. (1986) Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig. Dis. Sci., 31, 468-475.
80. Bellentani, S., Tiribelli, C., Saccoccio, G. et al. (1994) Prevalence of chronic liver disease in the general population of Northern Italy: the Dyonisos study. Hepatology, 20(6), 1442-1449.
81. Houghton, M., Weiner, A., Han, J., Kuo, G. and Choo, Q. L. (1991) Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology, 14, 381-388.
82. Sakamuro, D., Furukawa, T. and Takegami, T. (1995) Hepatitis C virus non-structural protein NS3 transform NIH 3T3 cells. J. Virol. 69(6), 3893-3896.
83. Simmonds, P., Smith, D. B., McOmish, M. et al. (1994) Identification of genotypes of hepatitis C virus by sequence comparison in the Core, El and NS-5 regions. J. Gen. Virol, 75, 1053-1061.
84. Okamoto, H., Kojima, M., Okada, S-I. et al. (1992) Genetic drift of hepatitis C virus during an 8.2 year infection in a chimpanzee: variability and stability, Virology, 190, 894-899.
85. Pozzato, G., Kaneko, S., Moretti, M. et al. (1994) Different genotypes of HCV are associated with chronic liver disease of different severity. J. Med. Virol, 43, 291-296.
86. Okamoto, H., Sugiyama, Y., Okada, S. et al. (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol., 73, 673-679.
87. Simmonds, P. (1995) Variability of hepatitis C virus. Hepatology, 67, 570-583.
88. Brown, E. A., Zhang, H., Ping, H-L. et al. (1992) Secondary structure of the 5′ nontranslated region of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res., 20, 5042-5045.